Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes

Many risk factors have been identified for breast cancer. The potential causality for some of them remains uncertain, and few studies have comprehensively investigated these associations by molecular subtypes. We performed a two‐sample Mendelian randomization (MR) study to evaluate potential causal associations of 23 known and suspected risk factors and biomarkers with breast cancer risk overall and by molecular subtypes using data from the Breast Cancer Association Consortium. The inverse‐variance weighted method was used to estimate odds ratios (OR) and 95% confidence interval (CI) for association of each trait with breast cancer risk. Significant associations with breast cancer risk were found for 15 traits, including age at menarche, age at menopause, body mass index, waist‐to‐hip ratio, height, physical activity, cigarette smoking, sleep duration, and morning‐preference chronotype, and six blood biomarkers (estrogens, insulin‐like growth factor‐1, sex hormone‐binding globulin [SHBG], telomere length, HDL‐cholesterol and fasting insulin). Noticeably, an increased circulating SHBG was associated with a reduced risk of estrogen receptor (ER)‐positive cancer (OR = 0.83, 95% CI: 0.73‐0.94), but an elevated risk of ER‐negative (OR = 1.12, 95% CI: 0.93‐1.36) and triple negative cancer (OR = 1.19, 95% CI: 0.92‐1.54) (Pheterogeneity = 0.01). Fasting insulin was most strongly associated with an increased risk of HER2‐negative cancer (OR = 1.94, 95% CI: 1.18‐3.20), but a reduced risk of HER2‐enriched cancer (OR = 0.46, 95% CI: 0.26‐0.81) (Pheterogeneity = 0.006). Results from sensitivity analyses using MR‐Egger and MR‐PRESSO were generally consistent. Our study provides strong evidence supporting potential causal associations of several risk factors for breast cancer and suggests potential heterogeneous associations of SHBG and fasting insulin levels with subtypes of breast cancer.

[1]  Jinbo Chen,et al.  Relationship of established risk factors with breast cancer subtypes , 2021, Cancer medicine.

[2]  I. Gram,et al.  Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[3]  Xia Jiang,et al.  Alcohol consumption and risk of breast and ovarian cancer: A Mendelian randomization study. , 2020, Cancer genetics.

[4]  T. Key,et al.  Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Tom M Palmer,et al.  Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis , 2020, PLoS medicine.

[6]  P. D. Jones,et al.  Genome-wide Association Analysis in Humans Links Nucleotide Metabolism to Leukocyte Telomere Length , 2020, American journal of human genetics.

[7]  C. Ulrich,et al.  Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis , 2020, Nature Communications.

[8]  D. Hunter,et al.  A Mendelian randomization analysis of circulating lipid traits and breast cancer risk. , 2019, International journal of epidemiology.

[9]  M. Munafo,et al.  Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study , 2019, Psychological Medicine.

[10]  M. Scholz,et al.  Genetic association study of eight steroid hormones and implications for sexual dimorphism of coronary artery disease. , 2019, The Journal of clinical endocrinology and metabolism.

[11]  Jack A. Taylor,et al.  Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses , 2019, bioRxiv.

[12]  Samuel E. Jones,et al.  Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study , 2019, BMJ.

[13]  K. Muir,et al.  Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study. , 2019, International journal of epidemiology.

[14]  V. Vacic,et al.  Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways , 2019, Nature Genetics.

[15]  Samuel E. Jones,et al.  Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms , 2019, Nature Communications.

[16]  Jonathan P. Beauchamp,et al.  Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences , 2019, Nature Genetics.

[17]  C. Lindgren,et al.  GWAS identifies 14 loci for device-measured physical activity and sleep duration , 2018, Nature Communications.

[18]  Dajiang J. Liu,et al.  Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use , 2018, Nature Genetics.

[19]  Jeffery M. Meyer,et al.  Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. , 2018, International journal of epidemiology.

[20]  Gretchen L. Gierach,et al.  Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype. , 2018, Cancer research.

[21]  Luke R. Lloyd-Jones,et al.  Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes , 2018, Nature Communications.

[22]  S. Ingles,et al.  Reproductive history, breast‐feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study , 2018, International journal of cancer.

[23]  B. Neale,et al.  Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.

[24]  Samuel E. Jones,et al.  Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry , 2018, bioRxiv.

[25]  Gary D Bader,et al.  Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.

[26]  Tom R. Gaunt,et al.  Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study , 2017 .

[27]  Maristella,et al.  Genomic analyses identify hundreds of variants associated with age at menarche and 1 support a role for puberty timing in cancer risk 2 , 2017 .

[28]  L. Bernstein,et al.  Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis , 2017, Breast Cancer Research.

[29]  N. Rothman,et al.  Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women. , 2016, Journal of the National Cancer Institute.

[30]  Kyle J. Gaulton,et al.  Genome-wide associations for birth weight and correlations with adult disease , 2016 .

[31]  A. Whittemore,et al.  Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent , 2016, PLoS medicine.

[32]  W. Willett,et al.  Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies. , 2016, International journal of epidemiology.

[33]  Jaana M. Hartikainen,et al.  Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. , 2015, Journal of the National Cancer Institute.

[34]  Andrew D. Johnson,et al.  Nature Genetics Advance Online Publication Large-scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility and Brca1-mediated Dna Repair , 2022 .

[35]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[36]  M. Koutsilieris,et al.  The role of the insulin-like growth factor-1 system in breast cancer , 2015, Molecular Cancer.

[37]  Heang-Ping Chan,et al.  Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk , 2022 .

[38]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[39]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[40]  Tanya M. Teslovich,et al.  Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.

[41]  Andrew D. Johnson,et al.  A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation , 2012, PLoS genetics.

[42]  Chuong B. Do,et al.  Genetic variants associated with breast size also influence breast cancer risk , 2012, BMC Medical Genetics.

[43]  R. Prentice,et al.  Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. , 2011, Journal of the National Cancer Institute.

[44]  Andrew W Roddam,et al.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.

[45]  Thomas E Rohan,et al.  Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. , 2009, Journal of the National Cancer Institute.

[46]  J. Chang-Claude,et al.  Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[48]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.